MiniViewer

Products	MiniViewer
Company	Telesensory Corporation
Item	MiniViewer
Features	The MiniViewer is easy to set up and use. Its high-contrast black-on-white or inverse white-on-black display provides added reading comfort. The compact Miniviewer is ready to use right out of the box. With its New carrying case and optional battery pack, the Miniviewer is a truly portable low vision solution.
Description	The Miniviewer magnifies text or color images 5 to 15 times. MiniViewers superior magnification, light weight and portable design offer you the ultimate in flexibility.
Info

Related medicine products :

1. Clarity Flex
2. Clarity Minimate
3. ERIS™ Clarity™ Urodynamic System

TAG: MiniViewer

Medicine Products:

Reduced 2000 series revised ETDRS Translucent Charts Cube Stereogram Stereo Test Frisby Stereo test Lumicon Red Filter

Breaking Medicine News(10 mins):Health News:The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession 2 Health News:Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine 2 Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2 Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3 Health News:Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment 2 Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2 Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3 Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4 Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5

[0] The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession [0] Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine [1] Obesity and Inactivity -- The Biggest Threat to the Nation's Health [0] Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment [0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans

Other Medicine News:Health News:Increase In The Number Of Doctors Reporting About Their Colleagues Abilities 2 Health News:Medicos Of The Calcutta Medical College Join Anti-Reservation Quota Protest 2 Health News:Moderate Exercise, Key To Breast Cancer Prevention 2 Health News:PAI-2 Plays a Pivotal Role in Eye Infections 2

Increase In The Number Of Doctors Reporting About Their Colleagues Abilities Medicos Of The Calcutta Medical College Join Anti-Reservation Quota Protest Non Smoking Women Less Prone To Lung Cancer Moderate Exercise, Key To Breast Cancer Prevention Cancer Cause Not Yet Ascertained PAI-2 Plays a Pivotal Role in Eye Infections

Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2 Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3 Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4 Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5 Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6 Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7 Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8 Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9 Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2 Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3 Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4 Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3 ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4 Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 1 Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 2 National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 1 National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 2 National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 3 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 1 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 2 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 3

[0] Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP [0] Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease [0] ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program